SEARCH

SEARCH BY CITATION

References

  • Azor, M., Gené, J., Cano, J. and Guarro, J. (2007) Universal in vitro antifungal resistance of genetic clades of the Fusarium solani species complex. Antimicrob Agents Chemother 51, 15001503.
  • Barik, B.P., Tayung, K. and Jagadev, P.N. (2011) Molecular phylogeny and RNA secondary structure of Fusarium species with different lifestyles. Plant Pathol Quart 1, 205219.
  • Bills, G.F., Platas, G., Palaez, F. and Mazurekar, P. (1998) Reclassification of a pneumocandin-producing anamorph, Glarea lozoyensis, gen. et sp. nov., previously identified as Zalerion arboricola. Mycol Res 103, 179192.
  • Bills, G.F., Platas, G., Overy, D.P., Collado, J., Fillola, A., Jimenez, M.R., Martín, J., del Val, A.G. et al. (2009) Discovery of the parnafungins, antifungal metabolites that inhibit mRNA polyadenylation, from the Fusarium larvarum complex and other Hypocrealean fungi. Mycologia 101, 449472.
  • Cauteren, H., Lampo, A., Vandenberghe, J., Vanparys, P., Coussement, W., Coster, R. and Marsboom, R. (1989) Toxicological profile and safety evaluation of antifungal azole derivatives. Mycoses 32, 6066.
  • Chen, Y.L., Lehman, V.N., Averette, A.F., Perfect, J.R. and Heitman, J. (2013) Posaconazole exhibits in vitro and in vivo synergistic antifungal activity with caspofungin or FK506 against Candida albicans. PLoS One 8, e57672.
  • Denning, D.W. (2003) Echinocandin antifungal drugs. Lancet 362, 11421151.
  • Douglas, C.M., D'Ippolito, J.A., Shei, G.J., Meinz, M., Onishi, J., Marrinan, J.A., Li, W., Abruzzo, G.K. et al. (1997) Identification of the FKS1 gene of Candida albicans as the essential target of 1,3-beta-D-glucan synthase inhibitors. Antimicrob Agents Chemother 41, 24712479.
  • Emri, T., Majoros, L., Tóth, V. and Pócsi, I. (2013) Echinocandins: production and applications. Appl Microbiol Biotechnol 97, 32673284.
  • Falagas, M.E., Roussos, N. and Vardakas, K.Z. (2010) Relative frequency of albicans and the various non-albicans Candida spp among candidemia isolates from inpatients in various parts of the world: a systematic review. Int J Infect Dis 14, e954e966.
  • Finberg, R.W. and Guharoy, R. (2012) Clinical approach to treatment of fungal infections. In Clinical Use of Anti-Infective Agents ed Finberg, R.W. and Guharoy, R. pp. 105110. New York: Springer.
  • Harris, M.R. and Coote, P.J. (2010) Combination of caspofungin or anidulafungin with antimicrobial peptides results in potent synergistic killing of Candida albicans and Candida glabrata in vitro. Int J Antimicrob Agents 35, 347356.
  • Henrion, B., Chevalier, G. and Martin, F. (1994) Typing truffle species by PCR amplification of the ribosomal DNA spacers. Mycol Res 98, 3743.
  • Hochlowski, J.E., Whittern, D.N., Buko, A., Alder, L. and McAlpine, J.B. (1995) Fusacandins A and B; novel antifungal antibiotics of the papulacandin class from Fusarium sambucinum. II. Isolation and structural elucidation. J Antibiotics 48, 614618.
  • Iwamoto, T., Fujie, A., Sakamoto, K., Tsurumi, Y., Shigematsu, N., Yamashita, M., Hashimoto, S., Okuhara, M. et al. (1994) WF11899A, B and C, novel antifungal lipopeptides. I: Taxonomy, fermentation, isolation and physico-chemical properties. J Antibiotics 47, 10841091.
  • Johnson, M.D. and Mohr, J. (2010) Echinocandins for prevention and treatment of invasive fungal infections. In Antifungal Therapy ed Ghannoum, M.A. and Perfect, J.R. p. 219. New York: Infirma Healthcare. ‏
  • Korstanje, M.J. and Staats, C.C.G. (2009) Fungal infections in the Netherlands. Dermatology 190, 3942.
  • Laniado-Laborín, R. and Cabrales-Vargas, M.N. (2009) Amphotericin B: side effects and toxicity. Rev Iberoam Micología 26, 223227.
  • Maertens, J. (2006) Caspofungin: an advanced treatment approach for suspected or confirmed invasive aspergillosis. Int J Antimicrob Agents 27, 457467.
  • Maertens, J.A., Madero, L., Reilly, A.F., Lehrnbecher, T., Groll, A.H., Jafri, H.S., Green, M., Nania, J.J. et al.; for the Caspofungin Pediatric Study Group. (2010) A randomized, double-blind, multicenter study of caspofungin versus liposomal amphotericin B for empiric antifungal therapy in pediatric patients with persistent fever and neutropenia. Pediatr Infect Dis J 29, 415420.
  • Martos, A., Romero, A., González, M., González, A., Serrano, C., Castro, C. and Pemán, J. (2010) Evaluation of the E-test method for susceptibility testing of Aspergillus spp. and Fusarium spp. to three echinocandins. Med Mycol 48, 858861.
  • Miceli, M.H., Díaz, J.A. and Lee, S.A. (2011) Emerging opportunistic yeast infections. Lancet Infect Dis 11, 142151.
  • Moore, C.B., Oakley, K.L. and Denning, D.W. (2001) In vitro activity of a new echinocandin, LY303366, and comparison with fluconazole, flucytosine and amphotericin B against Candida species. Clin Microbiol Infect 7, 1116.
  • National Committee for Clinical Laboratory Standards (NCCLS). (2002) Reference method for broth dilution testing of yeasts. Approved Standard, 2nd edn, pp M27A2. Wayne, PA: National Committee for Clinical Laboratory Standards.
  • Nyfeler, R. and Keller, S.W. (1974) Metabolites of microorganisms, 143: echinocandin B, a novel polypeptide-antibiotic from Aspergillus nidulans var echinulatus—isolation and structural components. Helv Chim Acta 57, 24592477.
  • Odds, F.C., Brown, A.J. and Gow, N.A. (2003) Antifungal agents: mechanisms of action. Trends Microbiol 11, 272279.
  • Pfaller, M.A. (2012) Antifungal drug resistance: mechanisms, epidemiology, and consequences for treatment. Am J Med 125, S3S13.
  • Tayung, K., Barik, B.P. and Jha, D.K. (2010) Antifungal activity and biocontrol potential of metabolite produced by an endophytic Fusarium (MTCC-9622) against some postharvest pathogens. J Agric Technol 6, 409419.
  • Traxler, P., Gruner, J. and Auden, J.A. (1977) Papulacandins, a new family of antibiotics with antifungal activity, I. Fermentation, isolation, chemical and biological characterization of papulacandins A, B, C, D and E. J Antibiotics 30, 289296.
  • Vicente, M.F., Basilio, A., Cabello, A. and Pelaez, F. (2003) Microbial natural products as a source of antifungals. Clin Microbiol Infect 9, 1532.
  • Waldman, A., Gilhar, A., Duek, L. and Berdicevsky, I. (2001) Incidence of Candida in psoriasis—a study on the fungal flora of psoriatic patients. Mycoses 44, 7781.
  • Wisplinghoff, H., Bischoff, T., Tallent, S.M., Seifert, H., Wenzel, R.P. and Edmond, M.B. (2004) Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 39, 309317.